Eyal Shamir
- 2Articles
- 7.7KReads
- 2000Active
- 8Collaborators
About
Eyal Shamir has published research focused on the use of melatonin in patients with chronic schizophrenia and its potential effects on tardive dyskinesia. The work spans clinical topics in neurology and schizophrenia/schizoaffective disorders. Shamir's publications appeared in 2000 in Psychiatrist.com, collaborating frequently with Avner Elizur, Nava Zisapel, Yoram Barak, Abraham Weizman, and Igor Plopsky.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
